

22 Oct 2025
// PRESS RELEASE
https://www.gsk.com/en-gb/media/press-releases/positive-pivot-po-phase-iii-data-show-tebipenem-hbr-s-potential-as-the-first-oral-carbapenem-antibiotic-for-patients-with-complicated-urinary-tract-infections-cutis/

06 Sep 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/09/06/2510376/0/en/Spero-Therapeutics-Provides-Tebipenem-HBr-Program-Update-Following-Type-A-Meeting-with-the-U-S-Food-and-Drug-Administration.html